These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6628501)

  • 1. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.
    Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of calcium antagonists on plasma digoxin concentration.
    Pedersen KE
    Acta Med Scand Suppl; 1984; 681():31-6. PubMed ID: 6587754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.
    Hansen PB; Buch J; Rasmussen OO; Waldorff S; Steiness E
    Br J Clin Pharmacol; 1984 Dec; 18(6):817-22. PubMed ID: 6529522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of verapamil on the digoxin-induced inotropic effect in guinea-pig isolated atria.
    Dorigo P; Maragno I
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):80-8. PubMed ID: 4015262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration.
    Pedersen KE; Christiansen BD; Kjaer K; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1983 Jul; 34(1):8-13. PubMed ID: 6861442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of digoxin-induced inotropism during quinidine administration.
    Steiness E; Waldorff S; Hansen PB; Kjaergård H; Buch J; Egeblad H
    Clin Pharmacol Ther; 1980 Jun; 27(6):791-5. PubMed ID: 7379447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.
    Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R
    Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil and digoxin: interactions in the rat.
    Kaplanski J; Weinhouse E; Topaz M; Genchik G
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):377-88. PubMed ID: 6665298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiloride-induced changes in digoxin dynamics and kinetics: abolition of digoxin-induced inotropism with amiloride.
    Waldorff S; Hansen PB; Kjaergård H; Buch J; Egeblad H; Steiness E
    Clin Pharmacol Ther; 1981 Aug; 30(2):172-6. PubMed ID: 7249501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between verapamil and digoxin in Langendorff-perfused rat hearts: the role of inhibition of P-glycoprotein in the heart.
    Aylin Arici M; Kilinc E; Demir O; Ates M; Yesilyurt A; Gelal A
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):847-52. PubMed ID: 22545967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.
    Hedman A; Angelin B; Arvidsson A; Beck O; Dahlqvist R; Nilsson B; Olsson M; Schenck-Gustafsson K
    Clin Pharmacol Ther; 1991 Mar; 49(3):256-62. PubMed ID: 2007320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.
    Johnson BF; Wilson J; Marwaha R; Hoch K; Johnson J
    Clin Pharmacol Ther; 1987 Jul; 42(1):66-71. PubMed ID: 2954736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs.
    Belz GG; Doering W; Munkes R; Matthews J
    Clin Pharmacol Ther; 1983 Apr; 33(4):410-7. PubMed ID: 6831819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
    Doering W
    Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of digoxin at comparable concentrations in tissues of fetal and adult sheep.
    Berman W; Ravenscroft PJ; Sheiner LB; Heymann MA; Melmon KL; Rudolph AM
    Circ Res; 1977 Nov; 41(5):635-42. PubMed ID: 908110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium.
    Cooper SJ; Kelly JG; Johnston GD; Copeland S; King DJ; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):21-5. PubMed ID: 6743487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial effects and pharmacokinetics of digoxin and ouabain in protein-deficient guinea pigs.
    Varma DR
    Can J Physiol Pharmacol; 1980 May; 58(5):564-7. PubMed ID: 7417884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.